Clinical Trial Update: Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

View source ↗

Summary

Update on a clinical trial evaluating biomarkers for recurrent hepatitis C infection after liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Alberta | Conditions: Hepatitis C Virus | Status: COMPLETED